by mmatthews
12/2/2008 4:05:00 PM
Started out my day by talking tomosynthesis with the
folks from Hologic and later Siemens. Both vendors are showcasing new
technology for this next generation of breast imaging, which some experts say
may ultimately replace mammo. But the works-in-progress are pending FDA
approval. The good news is that when tomosynthesis does hit the U.S. market, it
should be able to catch more breast cancers at a much earlier stage. The key to
better detection with this method is the multiple slices and 3D reconstructions
– allowing clinicians to detect cancer quickly and sooner. Some say it could
lower recall rates by as much as 40%. …. While tomosynthesis offers a huge
potential to revolutionize breast care, it’s still a bit off in the future.
Even so, it’s another stride forward in women’s imaging solutions. We’ll keep
an eye on this subject.